Investors

Presentations

Recent Videos and Audio Interviews

Why invest in ZEN?

Actively commercializing our existing graphene-based product IP in the personal protective equipment and air filtration markets
Pursuing a potential graphene-based antibiotic, antiviral, and antifungal compound that could be a potential medical breakthrough treatment for human-contracted pathogens
Vertical integration strategy focused on development of graphene production capacity, supply agreements and our 100% owned Albany Pure™ Graphite deposit
Building our IP Portfolio by developing partnerships and securing new IP in high-growth areas like advanced materials, clean tech, green energy and healthcare solutions
Experienced business-oriented management team that is invested into the company
Extensive government support for research and development

Company Info

Company name: ZEN Graphene Solutions Ltd.
Traded on: TSX Venture Exchange
Stock symbol: ZEN
CUSIP: 98935P108
ISIN: CA98935P1080

Legal Counsel

Irwin Lowy Barristers & Solicitors LLP

217 W. Queen Street #401

Toronto ON M5V 0R2

Tel: 416-361-2818

Fax: 416-361-2519

www.irwinlowy.com

Transfer Agency

Capital Transfer Agency Inc.

390 Bay Street, Suite 920,

Toronto, ON, M5H 2Y2, Canada

Tel: (416) 350.5007

Fax: (416) 350.5008